Pharma Marketing News
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys
Share |

FDA Guidance on Responding to Unsolicited Requests for Off-Label Information
The Social Media Guidelines Nobody Expected!

All I Got Was This Lousy GuidanceTwo days after Christmas, on December 27, 2011, while most of us were still on vacation, the FDA quietly issued "Guidance for Industry Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices." Section VI. of this guidance addresses responding to unsolicited requests on public forums such as the Internet.

While this may not be the "social media" guidance many people were expecting, it does include guidelines for responding to unsolicited requests for off-label information encountered through "emerging electronic media."

This article takes a closer look at how the off-label guidelines apply to social media such as Youtube, Blogs, and Twitter.

Topics include:
  • A Bit of History
  • Defining "Off-label"
  • What We Expected Was This
  • In Best Interest of Public Health
  • Public vs. Private, Solicited vs. Unsolicited
  • Youtube and Solicited Requests
  • Blogger Example of "Solicited Request"
  • Proving Solicitation is Difficult
  • Twitter Example of "Solicited Request"
  • Private Responses and Serving the Public Interest
  • Sales and Marketing May be Seen, but Should NOT Be Heard From!
  • The Burden of Responding
  • Docket Open for Comments
  • Legal Challenges
  • Chart: FDA Guidance Translator
Download full article (PDF)

Issue: Vol. 11, No. 1
Publication date: 26 January 2012
Word Count: 3,784

Find other articles in related Topic Areas:

Vol 11, #1 Contents

Contact Information
Pharma Marketing News

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.